Magnesium bisglycinate and magnesium glycinate are chelated forms of magnesium supplements commonly available in the UK. Many people wonder whether these represent different compounds or if one offers advantages over the other. In practice, magnesium bisglycinate and magnesium glycinate typically refer to the same chemical structure, where one magnesium ion is bound to two glycine molecules. Both forms are valued for their superior gastrointestinal tolerability compared to some other magnesium supplements. Understanding the relationship between these terms helps you make informed decisions about supplementation and ensures you select products based on quality and elemental magnesium content rather than assumed differences in efficacy.

What Are Magnesium Bisglycinate and Magnesium Glycinate?

Magnesium bisglycinate and magnesium glycinate are chelated forms of magnesium supplements that are widely available in the UK. Understanding the relationship between these two terms is essential for making informed choices about supplementation.

In practice, magnesium glycinate and magnesium bisglycinate (also known as magnesium diglycinate) typically refer to the same compound. The prefix 'bis-' indicates that one magnesium ion is bound to two glycine molecules. Despite some products being labelled as 'magnesium glycinate', most commercially available supplements actually contain the bisglycinate form, where magnesium is chelated with two glycine molecules.

These forms are classified as amino acid chelates rather than salts. The chelation process involves forming a protective structure around the mineral, which may help prevent it from interacting with other dietary components that might otherwise inhibit absorption.

Both forms are valued for their superior tolerability compared to some other forms such as magnesium oxide or magnesium sulphate. The glycine component itself is an amino acid that plays various roles in the body, though the clinical relevance of the glycine content at typical supplement doses remains uncertain.

In the UK market, products may be labelled as either magnesium glycinate or magnesium bisglycinate, and their clinical effects are generally considered equivalent. These products are regulated as food supplements under food law (overseen by the Food Standards Agency and Office for Product Safety and Standards) rather than as medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) becomes involved only when determining whether products making medicinal claims should be classified as medicines rather than supplements.

Absorption and Bioavailability Comparison

When comparing magnesium bisglycinate and magnesium glycinate, the key consideration is bioavailability—the proportion of magnesium that is absorbed and becomes available for physiological use. Current evidence suggests that these two forms have essentially equivalent bioavailability profiles, as they typically represent the same chemical structure.

Chelated magnesium forms, including bisglycinate, may demonstrate better absorption compared to some inorganic magnesium forms. The chelation process may help protect the magnesium from forming insoluble complexes with substances such as phytates, oxalates, or phosphates in the gastrointestinal tract. However, it's important to note that absorption rates vary considerably between individuals and depend on many factors including dosage, formulation, and individual digestive health.

The mechanism of absorption for chelated magnesium may differ from inorganic forms. While inorganic magnesium is primarily absorbed as free magnesium ions, chelated forms may potentially be absorbed partially intact through different intestinal transport mechanisms. However, human evidence for these specific mechanisms remains limited.

Gastrointestinal tolerability is another important aspect of bioavailability. Magnesium forms that cause diarrhoea effectively reduce net absorption, as the mineral is expelled before it can be taken up by intestinal cells. Both magnesium glycinate and bisglycinate are associated with minimal laxative effects at recommended doses, making them suitable for individuals who experience digestive upset with other magnesium supplements.

There is insufficient comparative human evidence to show clinically meaningful differences between products labelled as glycinate versus bisglycinate when comparing supplements of equivalent magnesium content and quality. Other magnesium forms, such as citrate, may also offer good bioavailability for many people.

Which Form of Magnesium Should You Choose?

Given that magnesium bisglycinate and magnesium glycinate typically refer to the same compound, the choice between products labelled with either name should be based on practical considerations rather than assumed differences in efficacy.

Product quality and manufacturing standards are paramount. In the UK, look for supplements produced according to recognised food safety standards such as HACCP, ISO 22000, or BRCGS. Third-party testing for purity and accurate labelling provides additional assurance. Some products may carry certification marks from organisations such as Informed-Sport, which is particularly relevant for athletes concerned about prohibited substances.

Elemental magnesium content varies between products and should guide your selection. Magnesium glycinate/bisglycinate typically provides approximately 10-14% elemental magnesium by weight, meaning a 500mg tablet might contain 50-70mg of actual magnesium. Always check the label for elemental magnesium content rather than the total compound weight. The NHS recommends that men aged 19-64 require 300mg of magnesium daily, whilst women in the same age group require 270mg, though these amounts should ideally come primarily from dietary sources.

Cost-effectiveness can vary considerably between brands. Since there is no evidence that one form outperforms the other, choosing the more affordable option of equivalent quality is entirely reasonable. However, extremely cheap supplements may indicate lower manufacturing standards or inaccurate labelling.

Additional ingredients merit consideration. Some formulations combine magnesium with other nutrients, though the clinical benefits of these combinations may vary. Others may contain unnecessary fillers, artificial colours, or allergens. Individuals with coeliac disease should verify that products are certified gluten-free.

For specific clinical situations, consultation with a healthcare professional is advisable. Children, individuals taking medications that interact with magnesium, those with renal impairment, heart block, myasthenia gravis, or pregnant women should seek guidance before commencing supplementation. Your GP or a registered dietitian can provide personalised recommendations based on your medical history and current medications.

Dosage and Safety Considerations in the UK

The appropriate dosage of magnesium glycinate or bisglycinate depends on individual circumstances, including dietary intake, age, medical conditions, and the reason for supplementation. The UK's Department of Health advises that adults should not take more than 400mg of magnesium daily from supplements unless advised by a clinician, as this is unlikely to cause harm for most people.

Common supplementation regimens typically range from 100-400mg of elemental magnesium daily, often divided into two doses to optimise absorption and minimise any potential gastrointestinal effects. For individuals addressing documented deficiency, higher doses may be appropriate under medical guidance. It is important to account for dietary magnesium intake when determining supplemental needs; good food sources include green leafy vegetables, nuts, seeds, whole grains, and legumes.

Adverse effects of magnesium glycinate/bisglycinate are generally mild when taken at recommended doses. The most common side effect is loose stools or diarrhoea, though this is less frequent with chelated forms compared to some other forms. Some individuals may experience nausea, abdominal cramping, or a metallic taste. These effects are typically dose-dependent and resolve with dose reduction.

Contraindications and cautions must be observed. Individuals with severe renal impairment should avoid magnesium supplementation unless specifically prescribed, as reduced kidney function impairs magnesium excretion and can lead to dangerous hypermagnesaemia. Symptoms of magnesium toxicity include muscle weakness, hypotension, cardiac arrhythmias, and respiratory depression—these constitute medical emergencies requiring immediate attention. Call 999 or attend A&E if you experience severe symptoms such as extreme weakness, difficulty breathing, or collapse after taking magnesium supplements.

Drug interactions are clinically significant. Magnesium can reduce the absorption of certain medications:

• Tetracycline antibiotics: separate by at least 2-3 hours

• Fluoroquinolone antibiotics: take 2 hours before or 4-6 hours after magnesium

• Bisphosphonates: follow specific administration instructions on the patient information leaflet

• Levothyroxine: separate by at least 4 hours

If you experience persistent symptoms that might indicate magnesium deficiency—such as muscle cramps, fatigue, irregular heartbeat, or numbness—consult your GP rather than self-treating. Blood tests can assess magnesium status, though serum levels do not always reflect total body stores. Routine screening in asymptomatic adults is not recommended; investigation should be based on clinical assessment.

If you suspect you've experienced side effects from a magnesium supplement, you can report this through the MHRA Yellow Card scheme.

Frequently Asked Questions